Golden Helix, Inc.
Enabling precision medicine
Bozeman, United States · Founded 2017 · $2.6M raised
- Headquarters
- Bozeman, Montana
- Employees
- 11–50
- Founded
- 2017
- Business Model
- B2B
- Website
- goldenhelix.com
- Total Funding
- $2.6M
- Last Round
- $2.2M GrantOct 2025
- Rounds
- 2
About
Golden Helix develops industry-leading clinical genomics software that empowers healthcare professionals and researchers to analyze and interpret next-generation sequencing (NGS) data. Their platform supports the full diagnostic workflow from variant analysis to clinical reporting, serving 400+ institutions across 60+ countries. The company has been enabling precision medicine since 1998.
Summary
Golden Helix, Inc. is a Biotech company based in Bozeman, United States, founded in 2017. It has raised $2.6M in total across 2 rounds, most recently a $2.2M Grant round in Oct 2025. Investors include National Institutes of Health.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2025
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Novel DNA sequencing architecture to scale the ultra low cost whole genome
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
